IWMB701 Breakfast Workshop – The Pathwork Tissue of Origin Test and Immunohistochemistry: Determining the Primary Site of Metastatic Cancer

6:30–7:45 am
CME/CE NOT APPLICABLE

The FDA-cleared Tissue of Origin Test determines the most likely tissue of origin by comparing the gene expression profile of FFPE tumor tissue to expression patterns of 15 known tumor types. This study compares the effectiveness of gene expression testing and immunohistochemistry in providing a diagnosis.

Presented by